INHIBRX BIOSCIENCES, INC. (INBX) Free cash flow 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$129.8MFY2025 · since FY2023: -$197.9M → -$129.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.8M | +34.1% |
| FY2024 | -$197.0M | +0.5% |
| FY2023 | -$197.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More INBX financial trends
INBX RevenueINBX Net incomeINBX Net marginINBX Gross profitINBX Gross marginINBX Operating incomeINBX Operating marginINBX Operating cash flowINBX Capital expendituresINBX Return on equityINBX Stock buybacksINBX Dividends paidINBX Total assetsINBX Total liabilitiesINBX Shareholders’ equityINBX overview →